Lipocine Inc. (LPCN) financial statements (2022 and earlier)

Company profile

Business Address 675 ARAPEEN DRIVE, SUITE 202
SALT LAKE CITY, 84108
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments44,61819,66714,0698,07821,46826,84044,383
Cash and cash equivalents2,95119,2179,7298,0783,2115,56120,008
Short-term investments41,6674504,340 18,25721,28024,375
Receivables247017393,34339145
Other undisclosed current assets1,5145,6615,54612,693408330350
Total current assets:46,38025,32919,63120,80925,21927,20944,878
Noncurrent Assets
Property, plant and equipment7 4197510376
Long-term investments and receivables2,022     400
Long-term investments2,022     400
Contract with customer, asset, net4,050   
Other noncurrent assets24242424313124
Total noncurrent assets:6,103242743106134500
TOTAL ASSETS:52,48225,35319,65820,85225,32527,34345,377
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,3063,2501,6321,1582,0951,3263,392
Accounts payable1,2891,5971,182671598246507
Accrued liabilities1,0161,6534494871,4971,0802,885
Debt2,3113,3333,3333,333   
Estimated litigation liability1,000   4,250  
Total current liabilities:5,6176,5844,9654,4926,3451,3263,392
Noncurrent Liabilities
Long-term debt and lease obligation 2,2573,8146,927   
Long-term debt, excluding current maturities 2,2573,8146,927   
Liabilities, other than long-term debt500      
Estimated litigation liability500      
Other undisclosed noncurrent liabilities7961,1704,591    
Total noncurrent liabilities:1,2963,4278,4066,927   
Total liabilities:6,91210,01113,37011,4186,3451,3263,392
Stockholders' equity
Stockholders' equity attributable to parent45,57015,3426,2889,43418,98026,01741,985
Common stock9742222
Treasury stock, value(41)(41)(41)(41)(41)(41)(41)
Additional paid in capital218,286187,408157,392147,533145,423131,481128,503
Accumulated other comprehensive loss(18) (0)(1)(5)(8)(33)
Accumulated deficit(172,666)(172,032)(151,067)(138,060)(126,400)(105,417)(86,445)
Total stockholders' equity:45,57015,3426,2889,43418,98026,01741,985
TOTAL LIABILITIES AND EQUITY:52,48225,35319,65820,85225,32527,34345,377

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues16,141 165428   
Gross profit:16,141 165428   
Operating expenses(12,995)(17,996)(13,065)(11,754)(21,218)(19,187)(18,382)
Operating income (loss):3,146(17,996)(12,900)(11,326)(21,218)(19,187)(18,382)
Nonoperating expense
(Other Nonoperating expense)
(3,780)(2,968)(343)(334)   
Interest and debt expense(203)235     
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes (235)236 236216174
Loss from continuing operations before equity method investments, income taxes:(837)(20,965)(13,007)(11,659)(20,982)(18,971)(18,208)
Other undisclosed income from continuing operations before income taxes203      
Loss from continuing operations before income taxes:(634)(20,965)(13,007)(11,659)(20,982)(18,971)(18,208)
Income tax expense(0)(0)(0)(1)(1)(1)(0)
Net loss available to common stockholders, diluted:(634)(20,965)(13,007)(11,660)(20,983)(18,972)(18,208)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(634)(20,965)(13,007)(11,660)(20,983)(18,972)(18,208)
Comprehensive loss:(634)(20,965)(13,007)(11,660)(20,983)(18,972)(18,208)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(18)014424(33)
Comprehensive loss, net of tax, attributable to parent:(652)(20,965)(13,006)(11,656)(20,979)(18,947)(18,241)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: